Rituximab therapy in adults with steroid-dependent nephrotic syndrome

Introduction Patients with steroid-dependent nephrotic syndrome (SDNS) suffer frequent relapse with adverse effects caused by long-term prednisolone treatment. Recently, the chimeric monoclonal antibody against the protein CD20 (rituximab – RTX) was observed to be efficacious and safe in the treatme...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Hongzhen Zhong, Hong-Yan Li, Tianbiao Zhou, Wenjuan Weng
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Termedia Publishing House 2019-10-01
Cyfres:	Archives of Medical Science
Pynciau:	steroid-dependent nephrotic syndrome rituximab efficacy safety
Mynediad Ar-lein:	https://www.archivesofmedicalscience.com/Rituximab-therapy-in-adults-with-steroid-dependent-nephrotic-syndrome,111931,0,2.html
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!